Skip to content

Analysis of Risk Factors for Liver Fibrosis in Wilson's Disease and Development of a Clinical Predictive Model

Analysis of Risk Factors for Liver Fibrosis in Wilson's Disease and Development of a Clinical Predictive Model

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2026000022
Enrollment
Unknown
Registered
2026-01-04
Start date
2024-10-02
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wilson's disease

Interventions

Observation group:A retrospective study was conducted to analyze risk factors without intervention.
Validation Group:A retrospective study was conducted to analyze risk factors without intervention.

Sponsors

The First Affiliated Hospital of Anhui University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 100 Years

Inclusion criteria

Inclusion criteria: Age and gender are unrestricted; participants must meet the disease diagnostic criteria; no prior treatment before admission; complete clinical records required for this study.

Exclusion criteria

Exclusion criteria: Subjects with a clear diagnosis of hepatic fibrosis or cirrhosis and inability to obtain clinical data; patients with fulminant hepatic failure (with or without hemolytic anemia) and decompensated cirrhosis; pregnant or breastfeeding women, or women intending to become pregnant; patients with other severe diseases (e.g., malignant tumors, hematopoietic system disorders).

Design outcomes

Primary

MeasureTime frame
Serum ceruloplasmin;Serum copper oxidase activity;Serum copper;24-hour urinary copper;Sheth Index;APRI Index;FIB-4 index;GPR model;Hyaluronic acid;Type IV collagen;Laminin;Type III procollagen N-terminal peptide;Digestive System Ultrasound Examination;Cranial imaging examination;Clinical Investigation of Traditional Chinese Medicine;

Secondary

MeasureTime frame
Age;Gender;Ethnic group;Allergy History;Marital Status;Body Mass Index;Confirmation Date;Presenting symptom;Disease classification;Corneal K-F ring;ATP7B Genetic Testing;disease course;Treatment Plan;HBV Infection Status;HCV Infection Status;Do you smoke?;Do you drink alcohol?;

Countries

China

Contacts

Public ContactTao Zhuang

The First Affiliated Hospital of Anhui University of Chinese Medicine

doersTZH@163.com13696776791

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026